Forget Lucid: Buy This TSX Stock Instead

Lucid Group stock is a high-risk bet for long-term investors given its steep valuation multiples.

| More on:
Choose a path

Image source: Getty Images

In the last two years, electric vehicle (EV) stocks have gained massive traction. Since the start of 2020, Tesla stock has returned over 1,100% to investors, and it also touched a market cap of US$1 trillion this year. Similarly, EV companies such as Lucid Group (NASDAQ:LCID) are yet to post any material revenue, but it already commands a market cap of US$72 billion at the time of writing. LCID stock has surged 338% in 2021 but is also down 24% from all-time highs.

Why is Lucid stock a high-risk bet?

Lucid’s Dream Edition line-up of EVs has a certified range of 520 miles on a single charge, which is the highest among any brand operating in this segment. The company is also part of a rapidly expanding addressable market given the accelerated shift towards clean energy solutions at the global level.

As of November 2021, Lucid had an order book of US$1.3 billion with 17,000 vehicle reservations. It forecasts sales to touch US$2 billion in 2022 and rise to US$10 billion in 2024. Tesla’s trailing 12-month sales surpassed the US$10 billion mark in mid-2017, and the EV leader was then valued at a market cap of US$70 billion. Tesla ended 2017 with US$11.78 billion in sales but still posted an operating loss of US$1.63 billion that year.

So, investors should understand that despite Lucid’s stellar growth prospects the stock remains overvalued at current levels. While the company ended Q3 with US$4.4 billion in cash, the automobile industry is capital intensive and cyclical, making LCID a high-risk bet right now. Several legacy players are also entering the EV space, which will negatively impact the pricing power of Lucid Group in the upcoming decade.

There is a good chance that Lucid will have to raise capital several times to fund its expansion plans, which will result in rising debt on its balance sheet or a dilution in shareholder wealth. Due to its steep valuation, LCID stock is also vulnerable if markets turn bearish or if it reports a quarter with lower-than-expected sales of earnings figures.

Auxly Cannabis has significant upside potential

A micro-cap stock valued at a market cap of $180 million, Auxly Cannabis (TSXV:XLY) has increased sales from just $8 million in 2019 to over $50 million in 2020. Analysts tracking Auxly forecast revenue to touch $84 million in 2021 and rise to $148 million next year, valuing the stock at a forward price-to-2022 sales multiple of 1.3 times, which is very reasonable.

Auxly Cannabis has successfully increased its market share in Canada’s Cannabis 2.0 business. It leads the vape sales in Canada, and Auxly’s three vape products are among the top five brands in the country.

In Q3 of 2021, Auxly Cannabis net sales almost doubled to $24.5 million, and it ended the quarter with a market share of 5.6%, making it the sixth-largest cannabis producer in Canada.

Analysts tracking Auxly stock have a 12-month average price target of $0.53, which offers investors an upside potential of almost 150% from current levels.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Tesla.

More on Cannabis Stocks

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »